Adjusted EBITDA - For the three months ended December 31, 2012, adjusted EBITDA was $20.3 million, an increase of 20.8% over the $16.8 million in adjusted EBITDA in the fourth quarter of 2011.
Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net loss below and is not a substitute for the GAAP equivalent.
Other financial data - We generated $24.8 million of cash flow from operations in 2012, of which $9.7 million was generated in the fourth quarter. We ended the quarter with $8.6 million of cash on hand, approximately $385.0 million of total debt and total leverage of 4.15x. Our total debt consisted of $250.0 million of senior unsecured notes due July 2019, $99.9 million outstanding under the senior secured revolving credit facility, $34.5 million outstanding under the working capital facilities in the U.K., and $575,000 in seller subordinated notes. As of the end of the year, our committed availability under our credit facilities was approximately $180 million, of which approximately $55 million is immediately available and the balance of approximately $125 million is available to fund future acquisitions.
ExamWorks is providing the following business outlook for the full year and the first quarter of 2013:
•Full year 2013 reported revenues are expected to increase organically by 5-7% from our 2012 pro forma revenues of approximately $574 million, excluding the effects of currency.
•Full year 2013 adjusted EBITDA margins are expected to range between 15.5% and 16.5% of reported revenues. The 50 bps change from our prior guidance is the result of significantly higher healthcare costs and employee enrollment into our benefit plans than originally anticipated. On a quarterly basis, adjusted EBITDA margins as a percentage of revenue will fluctuate between 15% and 17%.
•First quarter 2013 reported revenues are expected to range between $144 million and $148 million.
•First quarter 2013 reported adjusted EBITDA margins are expected to be approximately 15% of reported revenues.
•Starting in 2013, we intend to announce acquisitions as they close rather than guiding to an annual number. We believe that this will allow analysts and shareholders to more accurately and consistently model our expected results going forward.
About ExamWorks Group
ExamWorks Group, Inc. is a leading provider of independent medical examinations ("IMEs"), peer and bill reviews and related services. We help our clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services. ExamWorks is focused on providing clients a national presence while maintaining the local service and capabilities they need and expect.
Non-GAAP Financial Measures
In connection with the ongoing operation of our business, our management regularly reviews Adjusted EBITDA, a non-GAAP financial measure, to assess our performance. We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, acquisition-related transaction costs, share-based compensation expenses, and other non-recurring costs. We believe that Adjusted EBITDA is an important measure of our operating performance because it allows management, lenders, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of changes to our capitalization structure, acquisition related costs, income tax status, and other items of a non-operational nature that affect comparability.
Most Popular Stories
- Adam Levine Wins Big as 'The Voice' Crowns Champ
- Target Security Breach May Affect 40 Million Cardholders
- Archer Daniels Midland Moving HQ to Chicago
- Tyson Foods Charged With Civil Rights Violation
- 'Beyonce' Tops the U.S. Album Chart
- Texting With Vodka: Booze and Social Media Can Mix After All
- Bernanke Lets Congress Have It in Final Press Conference
- How to Protect Yourself After Target Data Breach
- Wall Street Falls a Day After Surge
- Hispanic PR Firm Launches Chicago Chapter